Search Results - "Welin, Mats"

In support of the European Union biosimilar framework by Schneider, Christian K, Borg, John J, Ehmann, Falk, Ekman, Niklas, Heinonen, Esa, Ho, Kowid, Hoefnagel, Marcel H, van der Plas, Roeland Martijn, Ruiz, Sol, van der Stappen, Antonius J, Thorpe, Robin, Tiitso, Klara, Tsiftsoglou, Asterios S, Vleminckx, Camille, Waxenecker, Guenter, Welin, Mats, Weise, Martina, Trouvin, Jean-Hugues

Get full text

Biosimilar products comparable to original preparations. The Medical Products Agency will not yet classify the agents as generics by Welin, Mats, Liliemark, Jan

Get more information

Quality-by-Design for biotechnology-related pharmaceuticals by Mandenius, Carl-Fredrik, Graumann, Klaus, Schultz, Torsten W., Premstaller, Andreas, Olsson, Ing-Marie, Petiot, Emma, Clemens, Christoph, Welin, Mats

“…The following article is a report from a workshop on Quality-by-Design (QbD) held at the 7th European Symposium on Biochemical Engineering Science (7 September…”
Get full text

Reply to In support of the European Union biosimilar framework by Schneider, Christian K, Borg, John J, Ehmann, Falk, Ekman, Niklas, Heinonen, Esa, Ho, Kowid, Hoefnagel, Marcel H, van der Plas, Roeland Martijn, Ruiz, Sol, van der Stappen, Antonius J, Thorpe, Robin, Tiitso, Klara, Tsiftsoglou, Asterios S, Vleminckx, Camille, Waxenecker, Guenter, Welin, Mats, Weise, Martina, Trouvin, Jean-Hugues

Get full text